In a recent interview with PAP Biznes, Proacta representatives announced that by the end of 2025, the company will focus on implementing projects on the Polish market. This decision is related to the growing demand for innovative medical solutions in the country and the dynamic development of its own products, in particular the Dbam o siebie Smart LAB platform.

The interview touched upon, among other things, the development of the B2B model, cooperation with medical universities, and pilot projects with large medical networks. The company also pointed to a significant increase in revenue (116% y/y in Q2 2025) and stable foundations for further investments.

The full interview is available here PAP Biznes – read